HPSE and neoplasm: Given that some variants of the heparanase protein (i.e., C-terminus domain, active site double-mutant, T5 splice variant) that lack enzymatic activity still promote tumor progression [50,51,52], a common concern is whether the enzymatic activity of heparanase is indeed the most critical determinant of its pro-tumorigenic and pro-metastatic effects.